At the Innovative Strategies for Patient Centered Clinical Research Conference, July 11-12, 2018 in Boston, MA will bring together the foremost leaders in Clinical Innovation, Clin
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh